|
FOR IMMEDIATE RELEASE
12 June 2007
OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO AUSHON BIOSYSTEMS
OXFORD, United Kingdom--(BUSINESS WIRE)--Oxford Gene Technology (OGT) and Aushon BioSystems are pleased to announce the completion of a licence agreement granting Aushon access to OGT’s “Southern array patents”, the fundamental patents covering the manufacture and marketing of oligonucleotide microarrays.
The granted license will enable Aushon BioSystems to manufacture and sell oligonucleotide microarrays, worldwide, and to perform services based on oligonucleotide arrays.
Sue Sutton, Vice President Licensing North America, at OGT said: “Successful discussions with Aushon have concluded with the granting of this license. This will enable them to extend their current offering to provide a range of microarray products to the market.”
John Austin, Executive Vice President, Chief Scientific Officer and Co-Founder at Aushon BioSystems added: “This agreement will enable Aushon to provide high quality, flexible and affordable oligonucleotide microarray products to our customers in life science research, drug discovery/development, and clinical diagnostics”.
The licence will remain valid for the patents’ lifetime. Financial details were not disclosed.
Notes to editors
About Oxford Gene Technology
- Founded in 1995 by the pioneer of Southern Blotting, Professor Sir Edwin Southern, OGT operates out of Begbroke Business Park near Oxford, with excellent access to a growing network of life science companies
- OGT offers a comprehensive custom microarray consultancy service, from experimental design through all stages to data analysis and interpretation. It has a strong proven track record in providing custom microarray service in a range of applications, and recently announced the launch of its first microarray product, an Escherichia coli K12 ChIP on chip, the first ChIP microarray product to be launched as part of OGT’s Prokaryotic Chip2 family
The key focus areas of OGT include:
- Array-based application products and services for life science research and molecular diagnostics. OGT’s flexible and cost-effective, customised DNA microarray service covers a range of applications, offering specialist support and assisting customers with every aspect of their research, from initial consultation and experimental design to probe selection, array design and fabrication through to data analysis and interpretation
- Development of innovative platform products for clinical research and diagnostics
- Licensing. OGT operates an open licensing policy which has successfully provided access for a number of companies to OGT's fundamental intellectual property, particularly in the area of microarrays
- Scientific collaborations to generate diagnostic biomarker intellectual property
For further information on OGT visit http://www.ogt.co.uk/
About Aushon Biosystems
Aushon BioSystems provides advanced microarray products, instruments and services for life-science research, drug discovery/development and clinical diagnostics. The Company's proprietary 2470 Arrayer -- now used in leading research centers around the world - enables researchers in the life science and pharmaceutical industries to create high quality arrays ranging from DNA to lysates. Aushon BioSystems is a privately held company based in Billerica, MA.
For further information on Aushon please visit the company’s website at
http://www.aushon.com
Contacts:
Dr. John Austin, Executive Vice President, Chief Scientific Officer & Co-Founder
Aushon BioSystems Inc.
43 Manning Rd
Billerica, MA 01821
T: 978-436-6400 ext. 223
F: 978-667-3970
E: john.austin@aushon.com
W: www.aushon.com
|
